Shanghai, China

Richard Thomas Beresis

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 6.2

ph-index = 11

Forward Citations = 351(Granted Patents)


Location History:

  • Shanghai, KR (2018)
  • Shanghai, CN (2015 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: **Richard Thomas Beresis: Innovator in Neuroactive Steroids**

Introduction

Richard Thomas Beresis is an accomplished inventor based in Shanghai, China, known for his significant contributions to the field of pharmacology and neuroactive steroids. With a remarkable portfolio of 27 patents, Beresis has made strides in developing innovative solutions for various central nervous system (CNS) disorders.

Latest Patents

Among his latest patents, Beresis has developed compounds including "19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof." These compounds are designed to address multiple CNS-related conditions such as sleep disorders, mood disorders, and traumatic brain injury. Furthermore, his patent on "Compositions and methods for treating CNS disorders" introduces neuroactive steroids that function as GABA modulators, offering potential therapeutic benefits for sedation and anesthesia.

Career Highlights

Richard has held prominent positions in noteworthy companies such as Sage Therapeutics, Inc. and Merck Sharp & Dohme Corporation. His experience in these pharmaceutical firms has been pivotal in advancing his research and development efforts in neuroactive steroid therapies.

Collaborations

Throughout his career, Beresis has collaborated with distinguished coworkers including Albert Jean Robichaud and Gabriel Martinez Botella. These partnerships have facilitated innovative research and the successful development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Richard Thomas Beresis stands out as a key inventor in the realm of neuroactive steroids, with his advancements promising significant impact on the treatment of complex CNS disorders. His ongoing work and patent portfolio continue to propel the field forward, offering hope for many individuals affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…